MNPR vs WDAY · $431.4M cap vs P/E 135, rev $5.19B
Monopar Therapeutics Inc (MNPR) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
MNPR currently screens at market cap $431.4M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the MNPR and WDAY stock pages for the full models.
Not investment advice.